DK0556152T3 - Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr - Google Patents

Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr

Info

Publication number
DK0556152T3
DK0556152T3 DK93810049T DK93810049T DK0556152T3 DK 0556152 T3 DK0556152 T3 DK 0556152T3 DK 93810049 T DK93810049 T DK 93810049T DK 93810049 T DK93810049 T DK 93810049T DK 0556152 T3 DK0556152 T3 DK 0556152T3
Authority
DK
Denmark
Prior art keywords
humans
animals
connective tissue
tissue diseases
pyridinium derivatives
Prior art date
Application number
DK93810049T
Other languages
Danish (da)
English (en)
Inventor
Laszlo Revesz
Rudolf Waelchli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0556152T3 publication Critical patent/DK0556152T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Soft Magnetic Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Paper (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93810049T 1992-01-31 1993-01-26 Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr DK0556152T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202139A GB9202139D0 (en) 1992-01-31 1992-01-31 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
DK0556152T3 true DK0556152T3 (da) 2002-04-08

Family

ID=10709643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93810049T DK0556152T3 (da) 1992-01-31 1993-01-26 Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr

Country Status (16)

Country Link
EP (1) EP0556152B1 (fi)
JP (1) JP3544549B2 (fi)
AT (1) ATE210645T1 (fi)
AU (1) AU663909B2 (fi)
CA (1) CA2088396A1 (fi)
CZ (1) CZ288038B6 (fi)
DE (1) DE69331293T2 (fi)
DK (1) DK0556152T3 (fi)
ES (1) ES2169723T3 (fi)
FI (1) FI104896B (fi)
GB (1) GB9202139D0 (fi)
HU (1) HU214677B (fi)
NO (1) NO180779C (fi)
PT (1) PT556152E (fi)
SG (1) SG43065A1 (fi)
SK (1) SK281137B6 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
US5723619A (en) * 1997-01-13 1998-03-03 Bayer Corporation Method for the synthesis of deoxypyridinoline
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
CN105801688A (zh) * 2016-04-14 2016-07-27 苏州博源医疗科技有限公司 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148766A (ja) * 1983-02-10 1984-08-25 Otsuka Pharmaceut Co Ltd ピリジン誘導体
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals

Also Published As

Publication number Publication date
JP3544549B2 (ja) 2004-07-21
EP0556152A1 (en) 1993-08-18
SK4293A3 (en) 1993-11-10
FI930367A (fi) 1993-08-01
NO180779C (no) 1997-06-18
CA2088396A1 (en) 1993-08-01
SK281137B6 (sk) 2000-12-11
HU9300108D0 (en) 1993-04-28
CZ10693A3 (en) 1993-12-15
ATE210645T1 (de) 2001-12-15
AU3210593A (en) 1993-08-05
FI104896B (fi) 2000-04-28
FI930367A0 (fi) 1993-01-28
ES2169723T3 (es) 2002-07-16
DE69331293D1 (de) 2002-01-24
NO180779B (no) 1997-03-10
PT556152E (pt) 2002-05-31
DE69331293T2 (de) 2002-07-18
SG43065A1 (en) 1997-10-17
GB9202139D0 (en) 1992-03-18
HUT70276A (en) 1995-09-28
AU663909B2 (en) 1995-10-26
JPH0641078A (ja) 1994-02-15
NO930284D0 (no) 1993-01-28
NO930284L (no) 1993-08-02
EP0556152B1 (en) 2001-12-12
CZ288038B6 (cs) 2001-04-11
HU214677B (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
EA199900853A1 (ru) Замещенные производные бензопирана для лечения воспалительных процессов
FI935672A0 (fi) Substituerade pyrazoler
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
DK0675886T3 (da) Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
DK0807633T3 (da) Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner
PT97049A (pt) Processo para a preparacao de ester de 1-metilo de n-l alfa-aspartil-fenilalanina (aspartame) e de produtos intermediarios e de derivados
DK0556152T3 (da) Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
BR0314461A (pt) Processo para a preparação de derivado de 2-aminometilpiridina
DE69737376D1 (de) Verfahren zur Synthese einer Oxonolverbindung
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
DE69119819T2 (de) L-Glutamsäure-Derivate
ES2082890T3 (es) Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ES2002325A6 (es) Un procedimiento para preparar un derivado de dihidropiridina